Sodium MRI may help physicians monitor the level of total sodium concentration levels in the brain, which increase dramatically in the advanced stages of MS.
Sodium magnetic resonance imaging may help physicians monitor the level of total sodium concentration (TSC) levels in the brain, which increase dramatically in the advanced stages of relapse-remitting multiple sclerosis, said French researchers in an article published in the journal Radiology.
The researchers sought to quantify brain sodium accumulation according to different stages of relapse-remitting multiple sclerosis (RR MS). It was known that there are abnormally high levels of sodium in the brain stem, cerebellum, and temporal pole, of patients in the early stages of the disease. What was not known were the concentrations as the disease progressed.
The study included three groups of subjects: 14 patients who had RR MS for fewer than five years (ranging from eight to 48 months) and 12 who had the disease for more than five years (ranging from 60 to 360 months), and 15 control subjects.
Using 3D 23Na MR imaging, data were obtained with a 3.0-T unit, and using specialized software, the researchers assessed the sodium concentration and location in the brain, and compared these findings with the patients’ level of disability. As expected, the patients with early RR MS had sodium build-up in the brain stem, cerebellum, and temporal pole, but they also found that among the patients with advanced disease, the TSC accumulation was dramatically increased throughout the brain.
This type of imaging may help physicians monitor the disease progress, wrote the authors, as well as provide target for potential therapies.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.